Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionStock Option · Derivative | 70,398 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · derivative · entry 10 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,399 Underlying: Common Stock · 70,398 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
SaleCommon Stock | 50,501 | $98.00 | $4,949,098.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 4 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,183.3689 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionCommon Stock | 50,501 | $54.19 | $2,736,649.19 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 3 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,684.3689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
SaleCommon Stock | 70,398 | $98.00 | $6,899,004.00 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 2 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,183.3689 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:50 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionCommon Stock | 70,398 | $58.34 | $4,107,019.32 |
DisclosureSEC source: 0001127602-22-020596 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,581.3689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionStock Option · Derivative | 9,546 | $0.00 Strike: $52.37 | $0.00 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · derivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,094 Underlying: Common Stock · 9,546 shares Expires 2029-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 5/31/2022. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 9,546 | $100.00 | $954,600.00 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,149.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionCommon Stock | 9,546 | $52.37 | $499,924.02 |
DisclosureSEC source: 0001127602-22-020590 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,695.9607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 38,873 | $0.00 Strike: $74.30 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 9 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,622 Underlying: Common Stock · 38,873 shares Expires 2031-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Option became exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 50,502 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 8 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,502 Underlying: Common Stock · 50,502 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 49,279 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · derivative · entry 7 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,558 Underlying: Common Stock · 49,279 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 38,873 | $95.00 | $3,692,935.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 38,873 | $74.30 | $2,888,263.90 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 50,502 | $95.00 | $4,797,690.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 4 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 50,502 | $54.19 | $2,736,703.38 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 49,279 | $95.00 | $4,681,505.00 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 626,273 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 21:00 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 49,279 | $58.35 | $2,875,429.65 |
DisclosureSEC source: 0001127602-22-018293 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2022 Filed Jun 6, 2022 21:05 UTC |
Shah Prem SEVP and Co-President of Retail
|
GrantCommon Stock (RSU) | 20,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016899 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,671 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments beginning 5/31/2023. Read SEC document |
| May 31, 2022 Filed Jun 6, 2022 21:18 UTC |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantCommon Stock (RSU) | 12,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016908 · form4.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,919 F1 · security: Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse on the third anniversary of the grant date. Read SEC document |
| May 31, 2022 Filed Jun 30, 2022 22:07 UTC Amendment |
Shah Prem SEVP and Co-President of Retail
|
GrantCommon Stock (RSU) | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-22-000731 · ownership.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This Form 4/A is being filed to amend a Form 4 filed by Mr. Shah on 06/06/2022, which incorrectly reported an award of Restricted Stock Units ("RSUs") with respect to 12,919 shares of the Issuer's common stock. The Form 4 filing was the result of an administrative error. Read SEC document |
| May 31, 2022 Filed Jun 30, 2022 22:13 UTC Amendment |
Chaguturu Sreekanth KEVP and Chief Medical Officer
|
GrantCommon Stock (RSU) | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000947871-22-000732 · ownership.xml · nonDerivative · entry 1 Chaguturu Sreekanth K · CIK 0001928726 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: This Form 4/A is being filed to amend a Form 4 filed by Dr. Chaguturu on 06/06/2022, which incorrectly reported an award of Restricted Stock Units ("RSUs") with respect to 12,919 shares of the Issuer's common stock. The Form 4 filing was the result of an administrative error. Read SEC document |
| May 11, 2022 Filed May 13, 2022 23:33 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 51 | $97.99 | $4,997.49 |
DisclosureSEC source: 0000947871-22-000569 · ownership.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,875 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:24 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,282.0186 | $97.99 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-22-014412 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,488.6249 Underlying: Common Stock · 1,282.0186 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:26 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,384 | $97.99 | $135,618.16 |
DisclosureSEC source: 0001127602-22-014413 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,892.2482 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:30 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,358.557 | $97.99 Strike: $0.00 | $133,125.00 |
DisclosureSEC source: 0001127602-22-014418 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,123.6827 Underlying: Common Stock · 1,358.557 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:39 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 1,282.0186 | $97.99 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-22-014439 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,222.8902 Underlying: Common Stock · 1,282.0186 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:39 UTC |
LUDWIG EDWARD JDirector
|
GrantCommon Stock | 165 | $97.99 | $16,168.35 |
DisclosureSEC source: 0001127602-22-014439 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,499 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:41 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,282 | $97.99 | $125,623.18 |
DisclosureSEC source: 0001127602-22-014445 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,526 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:43 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,409 | $97.99 | $138,067.91 |
DisclosureSEC source: 0001127602-22-014449 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:46 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,709.3581 | $97.99 Strike: $0.00 | $167,500.00 |
DisclosureSEC source: 0001127602-22-014455 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,142.2024 Underlying: Common Stock · 1,709.3581 shares Expires not disclosed F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:50 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,358 | $97.99 | $133,070.42 |
DisclosureSEC source: 0001127602-22-014462 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,760 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:51 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 3,112.5625 | $97.99 Strike: $0.00 | $305,000.00 |
DisclosureSEC source: 0001127602-22-014466 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,083.7262 Underlying: Common Stock · 3,112.5625 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:55 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 38 | $97.99 | $3,723.62 |
DisclosureSEC source: 0001127602-22-014472 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,852 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:57 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,760.3837 | $97.99 Strike: $0.00 | $172,500.00 |
DisclosureSEC source: 0001127602-22-014475 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,397.0255 Underlying: Common Stock · 1,760.3837 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 4,103 | $0.00 Strike: $74.30 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 18 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,723 Underlying: Common Stock · 4,103 shares Expires 2031-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Option becomes exercisable in three equal installments commencing 04/01/2022. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 5,719 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 17 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,596 Underlying: Common Stock · 5,719 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 3,157 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 16 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,469 Underlying: Common Stock · 3,157 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionStock Option · Derivative | 845 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · derivative · entry 15 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Underlying: Common Stock · 845 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 3,130 | $105.00 | $328,650.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 9 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,453.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 4,103 | $105.00 | $430,815.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 8 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 4,103 | $74.30 | $304,852.90 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 7 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,686.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 5,719 | $105.00 | $600,495.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 6 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 5,719 | $58.34 | $333,646.46 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 5 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,302.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 3,157 | $105.00 | $331,485.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 4 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 3,157 | $54.19 | $171,077.83 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 3 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,740.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
SaleCommon Stock | 845 | $105.00 | $88,725.00 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 2 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,583.24 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:51 UTC |
Shah Prem SEVP and Co-President of Retail
|
Exercise / conversionCommon Stock | 845 | $62.21 | $52,567.45 |
DisclosureSEC source: 0001127602-22-011910 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,428.24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 5,941 | $100.00 | $594,100.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · nonDerivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,149.9607 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionStock Option · Derivative | 27,166 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · derivative · entry 11 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,166 Underlying: Common Stock · 27,166 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 21:02 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionStock Option · Derivative | 16,161 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-22-011678 · form4.xml · derivative · entry 10 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,161 Underlying: Common Stock · 16,161 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, beginning on 4/1/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.